Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CB Therapeutics is commercializing proprietary precision fermentation and biosynthesis platforms to produce therapeutic tryptamines, cannabinoids, and other biologically active molecules for mental health, wellness, and food markets, with consistent purity, yield, and sustainability advantages. Some compounds (e.g., CBC, rare cannabinoids) are being supplied for therapeutic and research use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CB Medical.